Safety and antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors: Ovarian cancer cohort data Conference Paper uri icon

authors

  • Gao, B
  • Goh, J
  • Markman, B
  • Voskoboynik, M
  • Gan, HK
  • Coward, J
  • Palmieri, D
  • So, J
  • Meniawy, T
  • Chen, C
  • Xiang, X
  • Qiu, J
  • Xu, Y
  • Yang, L
  • Millward, M

publication date

  • December 1, 2019